Life Year Gained
Mostrando 1-12 de 14 artigos, teses e dissertações.
-
1. Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil – comparison of outcomes from different static model types
ABSTRACT Background: Influenza burden in Brazil is considerable with 4.2–6.4 million cases in 2008 and influenza-like-illness responsible for 16.9% of hospitalizations. Cost-effectiveness of influenza vaccination may be assessed by different types of models, with limitations due to data availability, assumptions, and modelling approach. Objective: To und
Braz J Infect Dis. Publicado em: 2018-01
-
2. O papel da integração regional na prevenção, gereniamento e resolução de conflitos na África : o caso da União Africana (UA) / The role of regional integration in conflict prevention, management, and resolution in Africa : the case of African Union (AU)
Socio-economic development in Africa is inseparable from warfare. In the mid 1990s alone, a third of sub-Saharan African countries had an active civil war, many of which, lasted a decade or more. Mass violence has afflicted nearly every African nation since independence. These conflicts are epic events in each nations history, destroying life, skills, wealth
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 07/07/2011
-
3. A longevidade do Aedes aegypti durante a estação chuvosa no município de Fortaleza. / The longevity of Aedes aegypti during the rainy season in Fortaleza.
Dengue fever constitutes a serious world health problem and the state of Ceará has been showing dengue fever since the year of 1986. In Fortaleza city, the capital of the state of Ceará it the was registered a great number of dengue epidemics, highlighting that the incidence of dengue fever is bigger during the rainy season rather than the non-rainy season
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 29/03/2010
-
4. Cost-effectiveness of entecavir versus lamivudine for the suppression of viral replication in chronic hepatitis B Patients in Brazil
Hepatitis B virus infection is an important public-health issue. Chronic patients have a higher risk of death due to complications, which increases health-care expenses in. Cost-effectiveness analysis of entecavir (ETV) versus lamivudine (LVD) for treatment of chronic hepatitis B, in e antigen (AgHBe)-positive and negative patients, based on two phase 3, con
Brazilian Journal of Infectious Diseases. Publicado em: 2008-10
-
5. O turismo na periferia do capitalismo: a revelação de um cartão postal
Tourism has expanded considerably over the past few decades, with an annual movement of almost a million tourists, revenues of 4 trillion dollars per year and the provision of more than 280 million people with a job. The gigantic proportions of this activity arouse the interest of the government and businessmen. Furthermore, the combined actions to exploit t
Publicado em: 2008
-
6. Cost-effectiveness analysis of implantable cardioverter defibrillator therapy (ICD) / Análise da relação custo-efetividade do tratamento com DCI - Desfibrilador Cardioversor Implantável
Objective: Cost-effectiveness analysis of implantable cardioverter defibrillator therapy (ICD) compared with conventional drug therapy. Literature review: The study comprised the conceptualization of techniques of economic evaluation, the methodology of appropriation of hospital procedure costs and different experiences on cost-effectiveness analysis applied
Publicado em: 2007
-
7. Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales.
OBJECTIVE--To assess the cost effectiveness of adding universal hepatitis B vaccination in infancy or pre-adolescence to a policy of selective vaccination of at risk groups. DESIGN--Costs of a selective policy and additional costs of universal vaccination policies were estimated from costs of vaccine delivery and published data on target populations. Additio
-
8. Adding years to life: effect of avoidable mortality on life expectancy at birth.
STUDY OBJECTIVE--The aim was to determine the number of years that could be gained by preventing avoidable deaths. DESIGN--The study arose from the concept of avoidable causes of death and life expectancy at birth. Four abbreviated life tables were computed. The first included all causes of death; the second excluded all avoidable causes of death; the third
-
9. Problems and solutions in calculating quality-adjusted life years (QALYs)
The quality-adjusted life-year (QALY) is a measure of the value of health outcomes. Since health is a function of length of life and quality of life, the QALY was developed as an attempt to combine the value of these attributes into a single index number. The QALY calculation is simple: the change in utility value induced by the treatment is multiplied by th
BioMed Central.
-
10. Relationship of weight gain in infancy to subcutaneous fat and relative weight at 10 1/2 years of age.
In a representative sample of 895 schoolchildren, aged between 9 years 10 months and 11 years 2 months, the risk of being overweight or obese was compared between those who had gained weight rapidly during infancy and those whose weight gain had been normal. A substantially increased risk ratio was found only in boys for whom a correlation analysis showed th
-
11. Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria
The Aliskiren in the Evaluation of Proteinuria in Diabetes (AVOID) trial demonstrated that adding aliskiren, an oral direct renin inhibitor, at a dosage of 300 mg/d to the highest approved dosage of losartan and optimal antihypertensive therapy reduces albuminuria over 6 mo among patients with type 2 diabetes, hypertension, and albuminuria. The cost-effectiv
American Society of Nephrology.
-
12. Effect of subject age on costs of screening for colorectal cancer.
STUDY OBJECTIVE--The aim was to estimate costs and yields of faecal occult blood screening and rescreening for colorectal cancer, for differing age cohorts. DESIGN--Cost and clinical data were used as the basis for modelling the expected costs, and cost savings, resulting from the treatment of screen detected cancers, as compared with cancers detected by sym